Heike Glauner

Simultaneous detection of intracellular target and off‐target binding of small molecule cancer drugs at nanomolar concentrations

R. Brock, S. Hannus, Ivo R. Ruttekolk, 2010, British journal of pharmacology.

A Quantitative Assessment of Costimulation and Phosphatase Activity on Microclusters in Early T Cell Signaling

G. Roth, R. Brock, M. Adjobo-Hermans, 2013, PloS one.

Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.

P. Scheurich, H. Wajant, M. Fotin‐Mleczek, 2004, The Journal of biological chemistry.

Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-κB Activation*

P. Scheurich, H. Wajant, M. Fotin‐Mleczek, 2004, Journal of Biological Chemistry.

Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4).

P. Scheurich, O. Janssen, H. Wajant, 2002, European journal of biochemistry.

The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange.

R. Brock, S. Hannus, Ivo R. Ruttekolk, 2009, Molecular immunology.

The intracellular pharmacokinetics of terminally capped peptides.

R. Brock, W. Verdurmen, J. Witsenburg, 2012, Molecular pharmaceutics.

Coupling to Polymeric Scaffolds Stabilizes Biofunctional Peptides for Intracellular Applications

R. Brock, J. Rademann, W. Verdurmen, 2011, Molecular Pharmacology.